An Open-Label Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of BMB-101 in Adults with either classic Absence Epilepsy (with or without Eyelid Myoclonia (EEM; Jeavons syndrome), OR Developmental Epileptic Encephalopathy (DEE)

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Zentner, Christian (Chief Investigator (CI))
  • Reutens, David Charles (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date5/12/24 → 5/12/26

Keywords

  • clinical trial
  • Epilepsy
  • Developmental Epileptic Encephalopathy